Therapeutic effects of antigen affinity-purified polyclonal anti-receptor of advanced glycation end-product (RAGE) antibodies on cholestasis-induced liver injury in rats

被引:10
作者
Xia, Peng [1 ]
Deng, Qing [1 ]
Gao, Jin [2 ]
Yu, Xiaolan [1 ]
Zhang, Yang [2 ]
Li, Jingjing [2 ]
Guan, Wen [1 ]
Hu, Jianjun [3 ]
Tan, Quanhui [3 ]
Zhou, Liang [1 ]
Han, Wei [2 ]
Yuan, Yunsheng [2 ,4 ]
Yu, Yan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai Municipal Key Lab Vet Biotechnol, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Pharm, Lab Regenerat Med, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
[3] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China
[4] Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
基金
中国国家自然科学基金;
关键词
Anti-RAGE; Liver injury; Liver fibrosis; Bile duct ligation; Hepatic stellate cell; HEPATIC STELLATE CELLS; COMMON BILE-DUCT; SERUM-LEVELS; RECEPTOR; BLOCKADE; ACTIVATION; EXPRESSION; ENDPRODUCTS; APOPTOSIS; FIBROSIS;
D O I
10.1016/j.ejphar.2016.03.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cholestasis leads to acute hepatic injury, fibrosis/cirrhosis, inflammation, and duct proliferation. We investigated whether blocking receptor of advanced glycation end-products (RAGE) with polyclonal anti RAGE antibodies (anti-RAGE) could regulate acute liver injury and fibrosis in a rat bile duct ligation (BDL) model. Male Wister rats received 0.5 mg/kg rabbit anti-RAGE or an equal amount of rabbit IgG by subcutaneous injection twice a week after BDL. Samples of liver tissue and peripheral blood were collected at 14 days after BDL. Serum biochemistry and histology were used to analyze the degree of liver injury. Quantitative real-time PCR (qPCR) and immunohistochemical staining were used to further analyze liver injury. Anti-RAGE improved the gross appearance of the liver and the rat survival rate. Liver tissue histology and relevant serum biochemistry indicated that anti-RAGE attenuated liver necrosis, inflammation, liver fibrosis, and duct proliferation in the BDL model. qPCR and western blotting showed significant reductions in interleukin-1 beta expression levels in the liver by treatment with anti-RAGE. Anti RAGE also significantly reduced the mRNA levels of alpha 1(1) collagen (Col1 alpha 1) and cholesterol 7 alpha-hydroxylase, and the ratio of tissue inhibitor of matrix metalloproteinase-1 to matrix metalloproteinases (MMPs) in the liver. In addition, anti-RAGE regulated the transcriptional level of Coll al and MMP-9 in transforming growth factor-beta-induced activated LX-2 cells in vitro. Anti-RAGE was found to inhibit hepatic stellate cell proliferation in vivo and in vitro. Therefore, anti-RAGE can protect the liver from injury induced by BDL in rats. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 110
页数:9
相关论文
共 42 条
[1]   Protective effect of resveratrol against oxidative stress in cholestasis [J].
Ara, C ;
Kirimlioglu, H ;
Karabulut, AB ;
Coban, S ;
Ay, S ;
Harputluoglu, M ;
Kirimlioglu, V ;
Yilmaz, S .
JOURNAL OF SURGICAL RESEARCH, 2005, 127 (02) :112-117
[2]   Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture [J].
Bandyopadhyay, Sarmistha ;
Friedman, Robin C. ;
Marquez, Rebecca T. ;
Keck, Kathy ;
Kong, Benjamin ;
Icardi, Michael S. ;
Brown, Kyle E. ;
Burge, Christopher B. ;
Schmidt, Warren N. ;
Wang, Yulei ;
McCaffrey, Anton P. .
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (12) :1753-1762
[3]  
BOTLA R, 1995, J PHARMACOL EXP THER, V272, P930
[4]   RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J].
Bucciarelli, LG ;
Wendt, T ;
Qu, W ;
Lu, Y ;
Lalla, E ;
Rong, LL ;
Goova, MT ;
Moser, B ;
Kislinger, T ;
Lee, DC ;
Kashyap, Y ;
Stern, DM ;
Schmidt, AM .
CIRCULATION, 2002, 106 (22) :2827-2835
[5]   Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease [J].
Butscheid, M. ;
Hauptvogel, P. ;
Fritz, P. ;
Klotz, U. ;
Alscher, D. M. .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (04) :415-418
[6]   Unchanged serum levels of advanced glycation endproducts in patients with liver disease [J].
Butscheid, Moritz ;
Schaefer, Christian ;
Brenner, Stefanie ;
Alscher, Dominik ;
Muerdter, Thomas ;
Niwa, Toshimitsu ;
Frischmann, Matthias ;
Pischetsrieder, Monika ;
Klotz, Ulrich .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 (06) :401-406
[7]   S100A4 promotes liver fibrosis via activation of hepatic stellate cells [J].
Chen, Lin ;
Li, Jie ;
Zhang, Jinhua ;
Dai, Chengliang ;
Liu, Xiaoman ;
Wang, Jun ;
Gao, Zhitao ;
Guo, Hongyan ;
Wang, Rui ;
Lu, Shichun ;
Wang, Fusheng ;
Zhang, Henghui ;
Chen, Hongsong ;
Fan, Xiaolong ;
Wang, Shengdian ;
Qin, Zhihai .
JOURNAL OF HEPATOLOGY, 2015, 62 (01) :156-164
[8]   Biliary decompression promotes Kupffer cell recovery in obstructive jaundice [J].
Clements, WDB ;
McCaigue, M ;
Erwin, P ;
Halliday, I ;
Rowlands, BJ .
GUT, 1996, 38 (06) :925-931
[9]   Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice [J].
de Meijer, Vincent E. ;
Sverdlov, Deanna Y. ;
Popov, Yury ;
Le, Hau D. ;
Meisel, Jonathan A. ;
Nose, Vania ;
Schuppan, Detlef ;
Puder, Mark .
PLOS ONE, 2010, 5 (06)
[10]   Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice [J].
Ekong, U ;
Zeng, S ;
Dun, H ;
Feirt, N ;
Guo, JC ;
Ippagunta, N ;
Guarrera, JV ;
Lu, Y ;
Weinberg, A ;
Qu, W ;
Ramasamy, R ;
Schmidt, AM ;
Emond, JC .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (04) :682-688